公司概覽
業務類別 Diagnostics & Research
業務概覽 Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.
公司地址 77 4th Avenue, Waltham, MA, USA, 02451
電話號碼 +1 781 663-6900
傳真號碼 --
公司網頁 https://www.revvity.com
員工數量 11000
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Joel S. Goldberg Senior Vice President, Administration, General Counsel and Secretary 美元 564.62K 24/02/2026
Mr. Tajinder S. Vohra Senior Vice President, Global Operations 美元 489.62K 24/02/2026
Dr. Prahlad R. Singh, PhD Director, President and Chief Executive Officer 美元 1.13M 16/03/2026
Ms. Miriame Victor Senior Vice President and Chief Commercial Officer 美元 503.27K 24/02/2026
Ms. Anita Gonzales Vice President and Chief Accounting Officer -- 24/02/2026
Mr. Maxwell Krakowiak Senior Vice President and Chief Financial Officer 美元 550.58K 24/02/2026
 
董事會成員
董事會 職務 更新日期
Mr. Michael A Klobuchar Independent Director 16/03/2026
Dr. Sophie V. Vandebroek, PhD Independent Director 16/03/2026
Dr. Peter Barrett,PhD Independent Director 16/03/2026
Mr. Alexis P. Michas Non-Executive Chairman of the Board 16/03/2026
Dr. Frank R. Witney,, PhD Independent Director 16/03/2026
Ms. Pascale Witz, M. Sc.,M.B.A. Independent Director 16/03/2026
Mr. Michel Pericles Vounatsos Independent Director 16/03/2026
Dr. Prahlad R. Singh, PhD Director, President and Chief Executive Officer 16/03/2026
Mr. Samuel R. Chapin Independent Director 16/03/2026
Dr. Michelle McMurry-Heath, M.D.,PhD Independent Director 16/03/2026
 
所屬ETF (更新日期: 02/05/2026 03:26)
代號 名稱 佔比% 持有日期
EUSAiShares MSCI USA Equal Weighted ETF<0.000001%06/03/2026
EVUSiShares ESG Aware MSCI USA Value ETF<0.000001%24/11/2025
FCTRFirst Trust Lunt US Factor Rotation ETF<0.000001%06/04/2026
FEXFirst Trust Large Cap Core AlphaDEX® ETF<0.000001%07/10/2025
FTAFirst Trust Large Cap Val AlphaDEX® ETF<0.000001%07/10/2025
FTLSFirst Trust Long/Short Equity ETF<0.000001%15/03/2026
GVLUGotham 1000 Value ETF<0.000001%05/03/2026
HELXFranklin Genomic Advancements ETF<0.000001%21/10/2025
HKNDHumankind US Stock ETF<0.000001%24/11/2025
HLALWahed FTSE USA Shariah ETF<0.000001%05/03/2026
ILCBiShares Morningstar U.S. Equity ETF<0.000001%05/03/2026
ILCGiShares Morningstar Growth ETF<0.000001%19/12/2025
ILCViShares Morningstar Value ETF<0.000001%04/03/2026
IMCBiShares Morningstar Mid-Cap ETF<0.000001%06/03/2026
IMCGiShares Morningstar Mid-Cap Growth ETF<0.000001%19/12/2025
IMCViShares Morningstar Mid-Cap Value ETF<0.000001%05/03/2026
KOKUXtrackers MSCI Kokusai Equity ETF<0.000001%25/11/2025
MFUSPIMCO RAFI Dyn Multi-Factor US Eq ETF<0.000001%23/03/2026
NUMVNuveen ESG Mid-Cap Value ETF<0.000001%25/11/2025
NZACState Street®SPDR®MSCIACWIClmPrsAlgndETF<0.000001%25/11/2025
  1    2    3    4    5    6    7    8    9   10    11    12  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.